Effects of gangliosides on the activity of the plasma membrane Ca2+-ATPase  by Jiang, Lei et al.
Biochimica et Biophysica Acta 1838 (2014) 1255–1265
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemEffects of gangliosides on the activity of the plasma
membrane Ca2+-ATPaseLei Jiang a,b,⁎, Misty D. Bechtel a,b, Jennifer L. Bean b,c, Robert Wineﬁeld d, Todd D. Williams d, Asma Zaidi a,b,e,
Elias K. Michaelis a,b, Mary L. Michaelis a,b
a Department of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, USA
b Higuchi Biosciences Center, University of Kansas, Lawrence, KS, USA
c Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA
d Structural Biology Center, University of Kansas, Lawrence, KS, USA
e Department of Biochemistry, Kansas City University of Medicine and Biosciences, Kansas City, MO, USAAbbreviations: CaM, calmodulin; CTXB, cholera toxin
1-Phenyl-2-decanoylamino-3-morpholino-1-propanol·
liquid chromatography; HPTLC, high performance thin l
liquid chromatography–mass spectrometry; MS, mass
exchanger; PMCA, plasma membrane Ca2+-ATPase;
concentration
⁎ Corresponding author at: Higuchi Biosciences Ce
University of Kansas, Lawrence, KS 66045, USA. Tel.: +1 7
5219.
E-mail address: jianglei@ku.edu (L. Jiang).
0005-2736/$ – see front matter © 2014 Elsevier B.V. All r
http://dx.doi.org/10.1016/j.bbamem.2014.01.003a b s t r a c ta r t i c l e i n f oArticle history:
Received 4 June 2013
Received in revised form 4 January 2014
Accepted 6 January 2014
Available online 14 January 2014
Keywords:
Aging
Ganglioside
Plasma membrane Ca2+-ATPase
Calcium
Neuraminidase
D(L)-threo-1-phenyl-2-decanoylamino-3-
morpholino-1-propanol (D-PDMP)Control of intracellular calcium concentrations ([Ca2+]i) is essential for neuronal function, and the plasma
membrane Ca2+-ATPase (PMCA) is crucial for the maintenance of low [Ca2+]i. We previously reported on loss of
PMCA activity in brain synaptic membranes during aging. Gangliosides are known to modulate Ca2+ homeostasis
and signal transduction in neurons. In the present study, we observed age-related changes in the ganglioside
composition of synaptic plasma membranes. This led us to hypothesize that alterations in ganglioside species
might contribute to the age-associated loss of PMCA activity. To probe the relationship between changes in
endogenous ganglioside content or composition and PMCA activity in membranes of cortical neurons,
we induced depletion of gangliosides by treating neurons with D-threo-1-phenyl-2-decanoylamino-3-
morpholino-1-propanol (D-PDMP). This caused a marked decrease in the activity of PMCA, which suggested a
direct correlation between ganglioside content and PMCA activity. Neurons treatedwith neuraminidase exhibited
an increase in GM1 content, a loss in poly-sialoganglioside content, and a decrease in PMCA activity that was
greater than that produced by D-PDMP treatment. Thus, it appeared that poly-sialogangliosides had a stimulatory
effect whereas mono-sialogangliosides had the opposite effect. Our observations add support to previous reports
of PMCA regulation by gangliosides by demonstrating thatmanipulations of endogenous ganglioside content and
species affect the activity of PMCA in neuronal membranes. Furthermore, our studies suggest that age-associated
loss in PMCA activity may result in part from changes in the lipid environment of this Ca2+ transporter.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Precise regulation of free intracellular Ca2+ concentrations ([Ca2+]i)
in neurons is highly dynamic and serves as the basis for a vast array of
signaling activities that are essential for neuronal viability and the integ-
rity of the entire nervous system. Neurons express multiple systems
that allow for rapid, transient Ca2+ pulses to initiate either short or
long-term signaling events and to terminate equally rapidly the Ca2+-
mediated signals by returning [Ca2+]i to normal resting levels. The
extrusion of intracellular Ca2+ across the plasma membrane takes placesubunit B; D/L-PDMP, D/L-threo-
HCI; HPLC, high performance
ayer chromatography; LC–MS,
spectrometry; NCX, Na+/Ca2+
[Ca2+]I, intracellular calcium
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85 864 4139; fax: +1 785 864
ights reserved.against a 10,000-fold gradient of this ion [1,2]. Two integral membrane
proteins mediate the extrusion of Ca2+, the plasma membrane Ca2+-
ATPase (PMCA) and the Na+/Ca2+ exchanger (NCX). The PMCA is a
high afﬁnity but low capacity system for pumping Ca2+ to the extracel-
lular medium [3–5], while the NCX is a low afﬁnity, high capacity
antiporter. The PMCA is responsible for the ﬁne-tuning of [Ca2+]i and
the maintenance of low resting [Ca2+]i [3–5].
The aging process in the brain is accompanied by increases in overall
Ca2+ content in brain neurons and synaptic terminals and a slower clear-
ance of intracellular Ca2+ from nerve endings following a depolarizing
stimulus [6,7]. Previously, we reported that the activity of PMCA in syn-
aptic plasmamembranes (SPMs) progressively decreases with age [8,9]
and suggested that this loss in activity may contribute to the aberrant
cellular Ca2+ overload observed in aging neurons.
The PMCA is an integralmembrane proteinwith ten transmembrane
domains [10]. The activity of this enzyme is regulated by multiple fac-
tors, including calmodulin (CaM) binding, proteolysis, protein kinases,
and acidic phospholipids in the membrane environment of the protein
[10,11]. In addition to themodulation of the enzyme by acidic phospho-
lipids residing in the inner leaﬂet of the plasma membrane, the activity
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introduced gangliosides, a class of glycosphingolipids that reside in the
outer leaﬂet of the plasma membrane [12,13]. However, the inﬂuence
of endogenous gangliosides on PMCA activity has not been explored.
Gangliosides are highly enriched in the central nervous system of
vertebrates. This is particularly true in the brain where they constitute
20–25% of the outer leaﬂet of neuronal membranes or 10–15% of the
total lipids in nerve ending (synaptosomal) membrane fractions [14].
Gangliosides participate in a variety of vertebrate cellular processes
such as toxin uptake and cell adhesion, growth, mobility, and differen-
tiation [15]. In the nervous system, gangliosides play critical roles in
neuritogenesis [16,17], synaptic transmission [18,19], axonal regenera-
tion, myelin stability [20], and signal transduction [21–24].
Due to their amphiphilic properties and their tendency to complex
with Ca2+ ions, gangliosides are implicated in the modulation of Ca2+
signaling and the maintenance of cellular Ca2+ homeostasis during
normal neuronal functioning [25]. Null mutant mice for GM2/GD2
synthase are deﬁcient in GM2, GD2, and all gangliotetraose gangliosides
and exhibit an impaired capacity for Ca2+ regulation, which supports
the hypothesis that themaintenance of Ca2+ homeostasis is a key func-
tion of complex gangliosides [26]. In rabbit skeletal muscles, both GM3
and GM1 can induce a conformational change in the sarco/endoplasmic
reticulum Ca2+-ATPase and alter the activity of this Ca2+-sequestering
enzyme [27]. At the plasmamembrane, GM1 activates indirectly a non-
voltage-gated channel, the transient receptor potential C5 channel, by
cross-linking withα5β1 integrin, thereby activating the integrin signal-
ing cascade and promoting Ca2+ inﬂux and the initiation of neurite
outgrowth [28,29]. However, unlike the information that exists with
regard to regulation of Ca2+ inﬂux into neurons by endogenous
gangliosides, there is only limited information on the effects of endoge-
nous gangliosides on Ca2+ efﬂux across the plasma membrane [25].
This is particularly truewith regard to the regulation of PMCAby endog-
enous gangliosides.
In our studies of the PMCAactivity in synapticmembranes,we found
that the highest activity was present in the raft domains, i.e., membrane
microdomains that are highly enriched in cholesterol and gangliosides
[30]. This observation led us to hypothesize that the content or compo-
sition of gangliosides in brain synaptic plasma membranes (SPMs) may
affect the activity of PMCAand that age-dependent alterations in endog-
enous ganglioside content or composition may contribute to the
age-associated loss of PMCA activity. Therefore, our goals in these
studies were: (1) to determine if endogenous SPM gangliosides change
with age; (2) to assess whether decreases in neuronal membrane
content of endogenous gangliosides lead to changes in PMCA activity;
and, (3)whether alterations in certain ganglioside species can selectively
increase or decrease the PMCA activity associated with neuronal
membranes. Our results indicated that: (1) the composition of ganglio-
sides in rat brain SPMs was altered during aging, and (2) the activity of
PMCA was highly sensitive to alterations in both content and composi-
tion of endogenous gangliosides in membranes of primary cortical
neurons. The ﬁndings from this study indicate a novel, CaM-
independent mechanism for the regulation of PMCA activity and the
modulation of Ca2+ signaling in the CNS.
2. Materials and methods
2.1. Reagents, antibodies and cell culture media
The following reagents were purchased fromMatreya LLC (Pleasant
Gap, PA): D- and L-threo-1-Phenyl-2-Decanoylamino-3-Morpholino-1-
Propanol·HCI (D-PDMP and L-PDMP, respectively), puriﬁed bovine
ganglioside mixture, and puriﬁed preparations of the ammonium salts
of GD1a, GD1b, and GT1b. Puriﬁed preparations of the ammonium salt
of GM1, all solvents (HPLC-grade only) used in lipid extraction or HPLC,
neuraminidase (Clostridium perfringens, type V), ouabain, thapsigargin,
oligomycin, ATP, horseradish peroxidase-coupled cholera toxin subunitB (CTXB), secondary anti-mouse and anti-rabbit antibodies, and
Phosphatase Inhibitor Cocktail 3, were obtained from Sigma-Aldrich
(St. Louis, MO). The bicinchoninic acid protein assay kit was from
Pierce-Thermo Scientiﬁc (Rockford, IL), the Protease Inhibitor Cocktail
3 and the high performance thin layer chromatography (HPTLC) plates
(Silica gel 60, 10 × 20 cm, Merck) were from Calbiochem-EMD
(San Diego, CA), and the puriﬁed sodium salt of GQ1b and anti-actin
antibody were from Santa Cruz Biotechnology (Santa Cruz, CA).
Tris-Glycine gradient gels (8–16%) and the serum-free Neurobasal™
cell media were purchased from Invitrogen (Carlsbad, CA), pan-PMCA
antibodies (monoclonal) and antibodies to isoform-speciﬁc PMCA1–4
were obtained from Afﬁnity Bioreagents (Golden, CO). The polyclonal
rabbit pan-PMCA antibody, raised against a 21 amino acid sequence in
the middle of the PMCA, was generated by our laboratory. All aqueous
HPLC solvents were prepared in 18 MΩ resistivity water.
2.2. Animals and isolation of brain SPMs
Fisher 344/Brown Norway hybrid (F344/BNF1) male rats at 6, 23,
and 34 months of age were obtained from the National Institute on
Aging colony maintained by Harlan Industries. All protocols were
implemented in accordance with NIH guidelines and approved by the
University of Kansas Institutional Animal Care and Use Committee.
The rats were quarantined for 2 weeks prior to their use in the studies.
The rats were anesthetized by CO2 inhalation, decapitated using a
guillotine, and the brains recovered quickly. The brains from individual
rats at each of the 3 ages were processed in parallel. Argon was bubbled
through all solutions immediately preceding their use. Eachwhole brain
was homogenized and processed for the isolation of synaptosomes by
discontinuous ﬁcoll density gradient centrifugation [30,31]. The synap-
tosomeswere lysed in 3 mMTris–HCl, at pH 8.5, buffer that contained a
cocktail of protease inhibitors, were centrifuged at 64,200 ×g for
15 min, and the SPM pellet resuspended in 10 mM Tris–HCl, 50 μM
MgCl2, and 0.32 M sucrose, at pH 7.4.
2.3. Capillary HPLC mass spectrometric analysis (LC–MS) of gangliosides
Gangliosides were extracted from SPM samples using the Folch
method [32]. Brieﬂy, SPMsamples (50 μl of eachwith an average protein
concentration of 14.8 mg/ml) were made up to a volume of 250 μl in
methanol:water (1:1, v/v) andmixedwith 4 ml of chloroform:methanol
(2:1, v/v). After the 25 min incubation, the solutions were centrifuged
(1000 ×g, 5 min). The aqueous (upper) phase was collected while the
chloroform layer was re-extracted three more times with 800 μl
methanol:water (1:1, v/v) each time. The aqueous extracts were com-
bined, dried under vacuum, and stored at −80 °C until use. Prior to
LC–MS analysis, samples were resuspended in 500 μl methanol:water
(1:1, v/v). HPLC analysis was performed on a nanoAcquity HPLC system
(Waters, Milford, MA). SPM samples and the mixture of bovine brain
gangliosides used as an external standard (5 μl of each) were initially
loaded (45 μl/min, 99% acetonitrile, 1% of 50 mM ammonium acetate
buffer, pH 5.6) onto a self-packed reversed phase C8 trap column
(Zorbax RX-SB/C8, 5 μm, Agilent Technologies, Santa Clara, CA) for
pre-concentration/desalting. After 3 min, the trap was switched in-
line with an Acquity UPLC HILIC column (BEH-Amide column, 1.7 μm
particle size, 1.0 × 50 mm, Waters). The gangliosides were resolved
with an acetonitrile/ammonium acetate buffer gradient. The total
column efﬂuent was introduced into a SYNAPT G2 hybrid quadrupole
time of ﬂight mass spectrometer (Waters). The instrument was
operated in sensitivity mode with a cone voltage of 45 eV and helium
was admitted to the collision (trap) cell. Spectra were acquired at a
mass range of 250–3000 m/z. Time to mass calibration was made
with NaI cluster ions acquired under the same conditions, and lock
mass correctedwith an auxiliary sprayer presenting the doubly charged
ion (m/z = 554.2614) from leucine enkephalin (YGGFL) peptide. Lock
mass spectra were acquired every 30 s. Quantiﬁcation of each class of
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peak-area data from extracted-ion-plots, targeting either the singly or
doubly charged ions, or both, for each ganglioside species. Mean limits
of detection and quantiﬁcation for each class of ganglioside were calcu-
lated using RMS signal to noise data (generated by QuanLynx) for each
injection.
Linear standard curves for each ganglioside were prepared as
follows. Individual gangliosides from commercial sources were dissolved
in DMSO at concentrations ranging between 1 and 4 mg/ml. The molar
concentration of these solutions was determined by the University of
Kansas Nuclear Magnetic Resonance Core laboratory using quantitative
NMR techniques [33]. Nine-point linear standard curves for the
gangliosides were generated by collecting data from triplicate injections
of the appropriate serial dilutions (in 1:1methanol:water) of the primary
stock solutions. These standard curves were then used to calibrate the
individual ganglioside abundance in a solution (40 μg/ml solution in
1:1 v/v methanol:water) made from the dried natural extract of
gangliosides GM1, GD1a, GD1b and GT1b obtained from bovine brains.
Instrument sensitivity was monitored by regularly injecting 5 μl of
the bovine–brain ganglioside mixture and using the calilbration data
to attenuate the sample for the effects of instrument drift in a
ganglioside speciﬁcmanner. To correct for the effect of signal attenuation
by the sample matrix, known amounts of bovine brain ganglioside mix-
ture were spiked into three randomly selected SPM extracts, and these
extracts were analyzed by LC–MS. The deﬁcit between the theoretical
and observed concentration served as an estimate of the matrix-
dependent signal attenuation for each class of ganglioside.
2.4. Neuronal cell cultures and manipulation of ganglioside levels
Dissociated cortical neuron cultures were established from 18-day
old Sprague Dawley fetuses as described previously [34,35]. Dissociated
neuronswere plated at a density of 1.5–1.75 × 106 cells/dish on 35 mm
tissue culture dishes. After 24 h, the medium was replaced by serum-
free Neurobasal™ medium [36]. Greater than 90% of the cells in the
primary cultures were neurons, based on morphological characteristics
and conﬁrmation with immunoﬂuorescent staining for glial ﬁbrillary
acidic protein and neuron speciﬁc enolase. Chronic depletion of cellular
gangliosides was achieved by treating neurons with D-PDMP, an inhibi-
tor of ganglioside synthesis [37]. Neurons were treated for 3 days with
10 μM D-PDMP added to the culture medium on day in vitro (DIV) 6.
L-PDMP, the enantiomeric form of D-PDMP, was used as a negative
control for the ganglioside depletion and was added to the neuronal
cultures in the same way as D-PDMP. Changes in the sialic acid levels
of the cell surface gangliosides were achieved through treatment with
neuraminidase [25]. The neuraminidase was prepared in Neurobasal™
medium, ﬁltered, and applied to each dish at 1 unit/ml on DIV 6. The
neuraminidase was present in the cultures for 3 days before the cell
collection.
2.5. HPTLC of gangliosides in neuronal membranes
Following exposure of neurons in culture to the agents noted above,
the cell culturemediumwas removed, the cellswerewashed twicewith
200 mMTris–HCl, at pH 7.4, and then lysed in 3 mMTris–HCl buffer, at
pH 8.0, containing a cocktail of protease inhibitors. The plasma
membrane-enriched fraction was obtained following centrifugation of
the lysate at 10,000 ×g at 4 °C for 20 min, and the resuspension of the
pellet in 3 mM Tris–HCl, at pH 8.0. For the ganglioside preparation,
cell particulate fractions (1 mg protein) were treated the same as for
the ganglioside extraction from SPM samples. All of the upper phases
were combined and KCl was added (ﬁnal concentration of 0.1 M). The
ganglioside-containing extracts were applied to Sep-Pak C18 cartridges
(Sep-Pak 1 cm3, 100 mg, Waters) that were pre-washed three times
alternately with 10 volumes of methanol and chloroform/methanol/
0.1 M KCl in water (3:48:47) [38]. Salts and other contaminantswere washed from the cartridge matrix with 10 volumes of water,
the gangliosides were eluted with 8 volumes of methanol, dried in a
SpeedVac, and re-dissolved in chloroform/methanol/water (2:1:0.1).
HPTLC was performed as described previously [39]. Brieﬂy, the tank
was saturated overnight with the developing solvent chloroform/
methanol/water (55:45:10) containing 0.02% CaCl2. Pre-coated
HPTLC plates were ﬁrst activated by heating at 100 °C for 15 min and
then cooled down to room temperature under desiccation. Ganglioside
standards containing a total of 5 μg of 4 major brain gangliosides and
the ganglioside samples from the cells were spotted as 7 mm streaks,
3 cm from the edge of the plate. The plate was developed for ~50 min
until the solvent ascended to within 1 cm of the top of the plate. After
being completely dried, the plate was sprayed with a ﬁne mist of
resorcinol/HCl/Cu2+ reagent [40] and heated in the oven at 110 °C for
1 h to allow visualization of the gangliosides. Plates were scanned in a
Kodak Image Station 4000MM PRO (Carestream Health Inc., Rochester
NY) using a colorimetric method at multi-wavelengths between 555
and 700 nm, and the density of each spot quantiﬁed using Carestream
Molecular Imaging Software 5.x (Carestream Health Inc.). Finally, the
level of ganglioside GM1 in 20 μg of each particulate sample protein
was used as a general index of membrane-associated gangliosides and
was determined by immunoblotting using CTXB (300 μg/ml) and
procedures identical to those previously published [30].
2.6. PMCA activity and protein immunoblotting
The activity of PMCA in the particulate fraction was determined by
monitoring the Ca2+-activated generation of Pi from ATP as described
previously [30,31,34]. For the immunoblot analyses of proteins, the
sample proteins were separated by SDS-PAGE, transferred to methanol-
activated PVDF membranes, and immunoreactivity measured as
described previously [34,41].
2.7. Data analysis
Statistical signiﬁcance of differences was assessed using Student's t
test for unpaired samples, except for the LC/MS estimates of SPM-
associated gangliosides in which one-way ANOVA with post-hoc
Tukey–Kramer analysis was applied.
2.8. Co-immunoprecipitation
SPMs containing 1.2 mg protein in 0.32 M sucrose were diluted 1:10
in 50 mMTris and 50 mMNaCl, at pH 7.4, containingprotease inhibitors
and phosphatase inhibitors. After centrifugation at 100,000 ×g for 1 h
to remove the sucrose, the membrane proteins were extracted by
resuspending the pellet in detergent-containing buffer (50 mM Tris,
50 mM NaCl, 0.1% NP-40, pH 7.4, protease inhibitors and phosphatase
inhibitors). The membranes were frozen in liquid nitrogen and thawed
at 37 °C 3–6 times andwere spun at 12,000 ×g for 20 min. The superna-
tant was collected as the detergent soluble fraction and the starting
material of the co-immunoprecipitation. A preclearing step was
performed with 7–10 μg of irrelevant antibody (mouse IgG, Sigma
I8765) for 2 h at 4 °C and 40 μl Protein A UltraLink™ resin (Thermo
Scientiﬁc, 50% slurry). The remaining protein lysate was incubated
with 2 μl (2–10 μg) of pan-PMCA monoclonal antibody overnight at
4 °C. The same sample co-incubated with mouse IgG served as a nega-
tive control. The antigen–antibody complexes were passed through
the Protein A UltraLink™ resin and ﬂow-through was collected. After
three washes with the detergent-containing buffer (see above) and
one with saline solution (150 mM NaCl), the resin was resuspended
in 100 μl sample buffer (42 mM Tris, 6.7% Glycerol, 2.7% SDS, 0.05%
Bromophenol blue) and boiled. The resuspended eluate was examined
for the yield of PMCA and the presence of gangliosides by immunoblot-
ting using the custom polyclonal pan-PMCA antibody to detect PMCA,
and cholera toxin to detect GM1.
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3.1. Age-dependent changes in ganglioside content and species in rat
brain SPMs
Gangliosideswere extracted fromSPMsprepared from the individual
brains of 6-, 23-,and 34 month old F344/BNF1 rats and were quantiﬁed
by LC–MS as described under Materials and methods. Five brain
gangliosides: GM1, GD1a, GD1b, GT1b, and GQ1b, all containing the
C18-sphingosine moiety, were detected. Quantiﬁcation of the ﬁrst four
gangliosides was possible because their abundance in all samples
exceeded their respective limits of quantitation (ranging between 0.5
and 20 pmol/injection, depending on the species). We were unable to
accurately measure GQ1b because its concentration in all samples,
regardless of age, barely exceeded the limit of detection for that species
(7 pmol/injection). The two most abundant species in terms of
the length of the fatty acid chain, i.e., 18:0 (Fig. 1A, n = 4) and 20:0
(Fig. 1B, n = 4), were detected for GM1, GD1a, GD1b, and GT1b. Two
patterns of age-related change in SPM gangliosides were observed
(Fig. 1). The abundance of the mono-sialoganglioside GM1, both C18Fig. 1.Alterations in SPM gangliosides with aging. Gangliosides were extracted from SPMs
isolated from the brains of F344/BNF1 rats at the ages of 6, 23, and 34 months and were
quantiﬁed by HPLC–MS. The 2 most abundant constituents for each ganglioside species
containingC18-spingosinebut varying in the fatty acyl chain are presented. (A)Ganglioside
species with C18-sphingosine and C18 fatty acyl chains; (B) Ganglioside species with C18-
sphingosine and C20 fatty acyl chains. Data are means ± SEM from 4 preparations of
SPMs per age. Statistical analysis was performed by one-way ANOVA with post-hoc
Tukey–Kramer. *indicates p b 0.05, **p b 0.01, ***p b 0.001.and C20 fatty acyl chain lengths, markedly increased with age (~1.5 fold
at 34 months for). In contrast, the levels of the poly-sialogangliosides
GD1a, GD1b, and GT1b, of both the species with C18 and the C20 fatty
acyl chain length, decreased between 6 and 23 months and were
restored to the 6-month level at 34 months.
3.2. Effects of D- and L-PDMP treatment of primary neuronal cultures on
neuronal structure, ganglioside and protein contents
To determine whether changes in the levels of endogenous
gangliosides in the SPMs might affect the PMCA activity, we designed
experiments in which we manipulated the endogenous levels of
gangliosides in primary neurons. PDMP is a synthetic analog of the cer-
amide backbone of gangliosides. The D-threo enantiomer of PDMP is an
inhibitor of UDP-glucose:ceramide glucosyltransferase, the enzyme that
is required for the ﬁrst step in glycosphingolipid synthesis. The L-threo-
PDMP lacks such activity and was used as a control for the effects of
treatment with D-PDMP. To assess whether PDMP caused toxicity in
primary cortical neurons, we treated the cells with either 10 μM
D-PDMP or 10 μM L-PDMP for 3 days as described under Materials and
methods. We observed that the untreated cells had a normal neuronal
structure with an intact neurite network, whereas the cells treated with
either enantiomer of PDMP tended to have fewer, shorter, and beaded
neurites (Fig. 2A). We have counted all recognizable neurites in 4 areas
of equal size for each of the images we obtained. The neurites were
counted in 4 images of cells per treatment condition. The results indicated
that control cultures had an average of 27.0 ± 1.3 neuritic processes per
5.7 cm2 area, D-PDMP-treated neuronal cultures had 17.7 ± 0.6 process-
es, and L-PDMP-treated neurons had 17.4 ± 1.0 processes. Both PDMP-
treated neurons had signiﬁcantly fewer neuritic processes than the con-
trol (p b 0.01 for both PDMP treatments) whereas there is no signiﬁcant
difference between D- and L-PDMP-treated neurons (p = 0.82). The
effects of PDMP enantiomers on themorphology of primary neurons ob-
served in our studies were consistent with the ﬁndings reported by
others [42,43]. In addition to the changes in themorphology of neurons
produced by D- or L-PDMP treatment, the total protein content of
neurons treated for 3 days was signiﬁcantly decreased compared with
neurons that were grown in the absence of exposure to either PDMP
enantiomer (n = 10, Fig. 2B). Both PDMP treatments led to a ~21%
protein loss, indicating a modest and equivalent neurotoxicity of the
two PDMP enantiomers.
We next examined the effect of D-PDMP on the ganglioside content
of the membrane-enriched particulate fraction from primary neuronal
cultures. In the initial studies, we used the binding of CTXB to GM1 as
an index of ganglioside content in neuronal samples. Actin immunore-
activity was used as the loading control and the ratio of GM1 to actin
was used to quantify the relative levels of gangliosides in the samples.
D-PDMP reduced signiﬁcantly the ganglioside content (~31%) compared
with the untreated control samples (n = 4) (Fig. 3A and B). On the
other hand, L-PDMP treatment did not alter the GM1 levels signiﬁcantly
(p = 0.46), comparedwith the untreated neuronal samples. The differ-
ence between D- and L-PDMP in terms of their effects onGM1 levels was
also signiﬁcant (n = 4). Furthermore, whenwe examined the effects of
D-PDMP and L-PDMP treatments on the most abundant species of
gangliosides present in neuronal membranes as revealed by HPTLC
analyses, we determined that D-PDMP caused a greater reduction in
the levels of most ganglioside species when compared with the effect of
either L-PDMP or the no-treatment condition (Fig. 3C). The effect of
D-PDMP on the combined abundance of the major poly-sialogangliosides
(GD1a, GD1b and GT1b) was approximately equal to that on the
mono-sialoganglioside GM1, and represented an ~38% decrease in the
levels of these membrane gangliosides as compared with neuronal
membranes from untreated cells (Fig. 3D). L-PDMP caused no signiﬁcant
decreases in either GM1 or the combined poly-sialoganglioside content
(p = 0.75 for GM1; p = 0.11 for poly-sialogangliosides) when com-
pared with the no-treatment condition. And, the differential effect of
control
control
0.25
0.20
0.15
0.10
0.05
0.00
10 µM
D-PDMP
10 µM
L-PDMP
10 µM
D-PDMP
10 µM
L-PDMP
A
B
Fig. 2. Effects of D- and L-PDMP on neuronal cultures. (A) Representative phase contrast images of primary cortical neurons with no treatment (control) or treated with either 10 μM
D-PDMP or L-PDMP for 3 days. Images were taken at a 20× magniﬁcation. A box used to count the neuritic processes is shown as an example on each image. The intact neurites in 4
boxes from each image obtained from 4 cultures per treatment condition were counted and the average number is calculated and reported in the text. (B) Effects of D- and L-PDMP on
protein levels in neuronal cultures. After a 3-day treatment with PDMP, cells were collected and lysed, and the total protein/dish was determined by the bicinchoninic acid assay. Data
are means ± SEM obtained from 10 experiments using different culture preparations. Statistical evaluation of the differences between control and treated cultures was determined
using Student's t-test for unpaired samples.
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L-PDMP treatment condition was a good control for the effects of treat-
ment with the enantiomer D-PDMP.
3.3. Effects of ganglioside depletion on PMCA content and activity of
neuronal membranes
Having characterized the effects of the PDMP enantiomers on neuro-
nalmembrane gangliosides,we sought to determinewhether decreases
in ganglioside content affected either the levels of PMCA protein
associated with neuronal membranes or the activity of this enzyme.
An equivalent amount of protein from each particulate fraction was
resolved by SDS-PAGE and probed with the pan-PMCA antibodies
(Fig. 4A). The PMCA to actin ratio was not statistically different between
the membranes obtained from the D-PDMP and those from neurons
treated with L-PDMP. The same was also true for the levels of PMCA in
D- or L-PDMP-treated neurons as compared with those of untreated
cells.
We next determined the activity of PMCA in themembrane fractions
of neurons treatedwith either the D- or L-enantiomers of PDMP. Because
cells have several ATPase systems, we ﬁrst validated that themajority of
the activity measured using our method was from PMCA by applying
the PMCA inhibitor to the assay. Carboxyeosin and lanthanum are
operating as PMCA inhibitors through different mechanisms with
carboxyeosin competing for the ATP binding site and lanthanum for
Ca2+. We tested the effect of the combination of the two inhibitors
and determined that at 200 μM carboxyeosin plus 500 μM lanthanum,
the maximal inhibition was 91.3 ± 1.6%, indicating that the enzyme
activity we measured was primarily due to PMCA. The speciﬁc activityof PMCA in neuronal membranes from untreated cells was 13.13 ±
0.31 nmol Pi·mg−1 protein·min−1, whereas that in membranes from
cells treated with D-PDMP was 26% lower than in the controls (9.70 ±
0.38 nmol Pi·mg−1 protein·min−1) (Fig. 4B). In contrast to the
effects of D-PDMP, L-PDMP had no statistically signiﬁcant effect on
the PMCA activity when compared with untreated controls (12.24 ±
0.25 nmol Pi·mg−1 protein·min−1, p = 0.06). The differential effect
of D-PDMP vs. L-PDMP on PMCA activity was signiﬁcant and indicated
that gangliosides either promoted or sustained the activation of
PMCA.
We also examined whether the PMCA activator CaM was a major
contributor to the sensitivity of PMCA to ganglioside depletion. The
PMCA activity was only marginally stimulated by the addition of CaM
to untreated primary neurons [34] and the D-PDMP-induced decrease
in the activity of PMCA could not be reversed by the addition of
300 nM exogenous CaM to the assay (data not shown). Finally, to rule
out the possibility that D-PDMPhad inactivated PMCAbybinding directly
to it, we added 10 μM (ﬁnal concentration) D-PDMP directly into an
assay system setup with cells not previously treated with D-PDMP.
The addition of D-PDMP into the PMCA assay medium had no effect
on the activity of the enzyme, indicating that D-PDMP does not exert a
direct effect on the enzyme (data not shown).
3.4. Neuraminidase-induced conversion of endogenous polysialyl
ganlgiosides to GM1 and effects on PMCA
The treatment of neuronal cultures with D-PDMP decreased the
levels of all species of membrane-associated gangliosides; thus no
conclusions could be drawn with respect to any selective effects on
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Fig. 3. Effects of PDMP treatments onGM1 levels. (A) Immunoblot analysis of GM1 following exposure to 10 μMD- or L-PDMP. Twentymicrograms of protein from cell particulate fractions
were loaded to each gel lane, andGM1wasdetected via CTXB. Anti-actin antibodywas used at 1:1000dilution. A representative immunoblot from4 independent experimentswith similar
results is shown. (B) Densitometric analyses of the levels of GM1 in particulate fractions normalized to actin as a loading control. Data represent means ± SEM from 4 experiments using
different cultures. (C) Ganglioside proﬁling by HPTLC. Gangliosides extracted from particulate fractions containing 1 mg protein were separated on an HPTLC plate. (D) Quantiﬁcation of
HPTLC images. Data are presented as means ± SEM from 5 experiments using different cultures. The total levels of GM1 vs. the combined content of polysialogangliosides (GD1a, GD1b,
GT1b) expressed in the control, D-PDMP- and L-PDMP-treated neurons are shown.
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the differential patterns of change in poly- vs. mono-sialogangliosides in
SPMs fromolder animals,we explored the possible differential sensitivity
of the enzyme to mono- vs. poly-sialogangliosides which might be
important in the regulation of the PMCA during the aging process. To
control the level of sialylation of gangliosides in the plasma membrane
of neurons we treated the cells with neuraminidase. This enzyme
hydrolyzes the α-glycosidic bonds between sialic acid and cell surface
glycoconjugates [44], thus converting polysialyl gangliosides to GM1,
a species resistant to neuraminidase-induced cleavage [25,45]. Neurons
in culture were exposed to C. perfringens neuraminidase at a higher
concentration than that employed in previous studies (1 unit/ml) [45]
and for a prolonged period (3 days) in order to compensate for the
fact that the incubations were conducted under non-optimal pH
conditions for enzyme activity [46].
Examination of the neuronal cultures by phase contrast microscopy
showed that the neuraminidase-treated primary neurons had darker,thickened neurites when compared with the untreated cells (Fig. 5).
These morphological changes would ﬁt the known induction of
neuritogenesis following neuraminidase treatment [45]. Yet, despite
the thickening of neuritic processes following neuraminidase treat-
ment, the total protein content of neuraminidase-treated neurons was
~15% less than that of untreated controls (p b 0.001, n = 8). With
respect to the ganglioside content of neuronal membrane preparations
fromneuraminidase-treated neurons, as expected, immunoblot labeling
of GM1 with CTXB revealed that the GM1 to actin ratio in particulates
of neuraminidase-treated neurons was ~2.5-fold higher than that in
particulates fromuntreated neurons (Fig. 6A). Quantiﬁcation of the gan-
glioside bands from HPTLC images (Fig. 6B) demonstrated that the
major di- (GD1a, GD1b) and tri-sialogangliosides (GT1b) were reduced
by a factor of 2–3 following exposure of neurons to neuraminidase,
while GM1 increased by approximately the same factor of 2–3 (Fig. 6C,
n = 3). Commercial preparations of neuraminidase are reported to
catalyze the hydrolysis of the N-acetylneuraminic acid group from
AB
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Fig. 4. Effects of ganglioside depletion on PMCA content and activity. (A) Immunoblot
analysis of PMCA following exposure to 10 μMD-or L-PDMP. Twentymicrogramsof protein
from cell particulate fractions were loaded to each gel lane. Anti-pan-PMCA and anti-actin
antibodieswere used at 1:1000 dilution. A representative immunoblot from 4 independent
experiments with similar results is shown. (B) The speciﬁc activity of PMCA in neuronal
particulate fractions (9 μg protein) from control cultures and D- or L-PDMP treated cultures
was assayed. The data represent means ± SEM from 4 different cell preparations.
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the GM2 level following exposure of primary cortical neurons to neur-
aminidase. This might have been due to the generally low level of ex-
pression of GM2 in neurons.
Immunoblot analyses using pan-PMCA antibodies indicated no
signiﬁcant changes in PMCA levels (PMCA to actin ratios, data not
shown) in primary neurons treated with neuraminidase compared
with controls. This suggests, once more, that alterations in endogenous
ganglioside composition of neurons did not affect the PMCA levels in
membranes. On the other hand, neuraminidase treatment did affect
the PMCA activity in neuronal membranes (Fig. 7). Membranes from
neurons treated with neuraminidase exhibited a ~39% decrease in the
speciﬁc activity of PMCA (8.57 ± 0.64 nmol Pi·mg−1 protein·min−1)
as compared with membranes from cultures not exposed to neuramini-
dase (13.95 ± 0.65 nmol Pi·mg−1 protein·min−1). The decrease incontrol
Fig. 5. Effects of neuraminidase on cultured neurons. Phase contrast images of primary cortical n
were taken at a 20× magniﬁcation.PMCA activity following neuraminidase treatment was coincident with
an increase in GM1 content and the decreases in poly-sialogangliosides.
The greater reduction in PMCA activity induced by neuraminidase
(39%) as compared with that induced by D-PDMP (26%) might indicate
that PMCA activity in neuronal membranes is up-regulated by poly-
sialogangliosides and down-regulated by GM1.
3.5. The expression of PMCA isoforms in brain SPMs compared with
neuronal particulates
The age-related changes in ganglioside content in neurons were
observed using SPM preparations from rat brain, whereas the effects
of manipulating ganglioside levels were determined in particulate
fractions from primary neuronal cultures. Since all measurements of
the effects of mono- and poly-sialogangliosides on PMCA activity were
obtained using particulate preparations from primary neuronal cultures,
it was important to assess the similarities in the expression of the four
isoforms of PMCA in SPMs from the brain and the particulate fraction
from primary neurons. To this end, we assessed the relative levels of
each of the four PMCA isoforms in SPMs vs. neuronal particulates by
immunoblot analysis (Fig. 8). We found that all isoforms were present
in both sample types although they were relatively less abundant in
the crude neuronal membrane fraction. This difference in PMCA abun-
dance was likely related to the higher level of plasmamembrane puriﬁ-
cation in the SPM fraction vs. the whole cell particulates. Despite the
lower enrichment in PMCA in the cell particulate fraction, all 4 isoforms
were present at similar levels proportionately represented in the two
preparations.
3.6. Association of gangliosides with PMCA
To determine if there is any direct interaction between gangliosides
and PMCA, we performed co-immunoprecipitation experiments with a
solubilized protein fraction of the brain SPMs. The SPM protein
complexes were extracted and solubilized by using the nonionic deter-
gent, NP-40, at a low concentration of 0.1% in order to extract the
complexes out of the membranes while maintaining the structures
and their possible interacting partners intact. The majority of PMCA
appeared in the detergent soluble fraction whereas GM1 showed
an opposite trend (Fig. 9 lanes 1 and 2). Co-immunoprecipitation of
PMCA was carried out using the monoclonal pan-PMCA antibody.
Mouse IgG was used as a negative control. The ﬂow-through and eluate
were collected and examined by immunoblotting using the polyclonal
pan-PMCA antibody to determine the PMCA yield and the speciﬁcity
of the immunoprecipitation (lanes 3–6). In the eluate, in addition to
the PMCA band at ~140 kDa, we observed two broad bands with
heavy staining at higher molecular weights (lane 5). Protein identiﬁca-
tion via gel electrophoresis followed by Coomassie staining and MS
analysis conﬁrmed that PMCA was also present in those two bands,neuraminidase
euronswith no treatment (control) or treatedwith neuraminidase at 1 unit/ml for 3 days
Fig. 7. Effects of neuraminidase treatment on PMCA activity. The speciﬁc activity of PMCA
wasmeasured inparticulate fractions from control or neuraminidase-treated neurons. The
data shown are the means ± SEM from 4 different cell preparations.
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Fig. 8. PMCA isoforms in SPMs and neuronal particulates. Fifteen micrograms of protein
from either SPMs or cell particulates were loaded to each gel lane for probing the levels
of pan PMCA and the 4 isoforms. The dilution of each primary antibody is: 1:1000 for
anti-pan-PMCA, 1:400 for anti-PMCA1, PMCA3, and PMCA4, and 1:2000 for anti-PMCA2.
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Fig. 6. Levels of GM1 and PMCA after exposure to neuraminidase. (A) Mean ratios of GM1
to actin after neuraminidase treatment. The results are from 4 experiments using different
cultures. (B) Representative HPTLC image showing the effect of neuraminidase exposure
on poly-sialoganglioside levels (n = 3 cultures). (C) Densitometric analysis of HPTLC
images from 3 different cell preparations. Data are presented as means ± SEM of GM1
vs. the combined content of poly-sialogangliosides.
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complexes. Densitometric measurement of PMCA bands in the starting
material (lane 1) vs. eluate (lane 5), factored by the total volume of
the sample, revealed that 52% of the total PMCA had been
immunoprecipitated. There was virtually no immunoreactivity in
the negative control (lane 6). GM1 did not seem to bind to the PMCA-
linked resin and thus appeared in the ﬂow-through (lane 3). No detect-
able amount of GM1 was observed in the eluate despite the loading
of a larger volume of the eluate (lane 5). This indicated that GM1
was not interacting with the PMCA proteins directly. Immunoblots of
ﬂow-through and eluate were also run to probe for GD1a by using an
anti-GD1a antibody, and results similar to those with GM1 wereobtained (data not shown), further conﬁrming that gangliosides did
not directly associate with the PMCA in neuronal membranes through
tight binding interactions.
4. Discussion
Using a high-resolution and high-sensitivity LC–MS method to
assess age-related changes in the relative abundance of speciﬁc
gangliosides in rat brain SPMs, we found that the levels of the major
brain gangliosides did change with age and that such changes were
different for the poly-sialogangliosides when compared with those of
the mono-sialogangliosides. The results of our studies pointed to
signiﬁcant decreases in GD1a and GT1b at 23 months of age, and a
PMCA
pan
GM1
1 2 3 4 5 6
Fig. 9. Test for direct interaction between PMCA and gangliosides. The membrane proteins were extracted from SPMs and solubilized by 0.1% NP-40. Co-immunoprecipitation was
performed by co-incubation of the detergent soluble fractionwithmonoclonal pan-PMCA antibody and Protein A UltraLink™ resin (seeMaterials andmethods). Flow-through and eluate
were both collected and analyzed via immunoblotting for the yield of PMCA using polyclonal pan-PMCA antibody (1:400 dilution) and the detection of GM1 using cholera toxin. Lane 1:
detergent soluble fraction, 5 μg protein loading (3.32 μl); Lane 2: detergent insoluble fraction, 5 μg (3.10 μl); Lane 3: ﬂow through, 12 μg (7.64 μl); Lane 4: ﬂow through of the negative
control, 12 μg (8.69 μl); Lane 5: eluate, 8 μl for PMCA and 40 μl for GM1 probing; Lane 6: eluate of the negative control, 8 μl for PMCA and 40 μl for GM1.
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of age. All values reported for changes in the content of various ganglio-
side species in older rats were compared with those in SPMs from
6 month old rats.
The LC–MS method employed in our studies utilized a trapping
strategy to simultaneously desalt and focus the gangliosides prior to
resolving them by HILIC. This approach enabled each of ﬁve major clas-
ses of gangliosides (GM1, GD1a, GD1b, GT1b, GQ1b) to be fully resolved,
despite the fact that they are chemically similar amphipathic molecules
and that GD1a and GD1b are isobaric. The high performancemass spec-
trometry (i.e., mass-resolution, accuracy, and fragmentation by MSe)
afforded substantive molecular speciation enabling us to differentiate
between co-eluting gangliosides and the C18:1 sphingosine family, as
well as between those that differed only in the length of their fatty
acyl chains (18:0 vs. 20:0). We also noted that the use of the limit of
quantitation (LoQ) as a measure of sensitivity was more appropriate
than the standard ganglioside quantitative techniques. The measure-
ment of the worst LoQ (20 pmol/injection for the GM1 with the 18:0
fatty acyl chain) was achieved in spite of the fact that this ganglioside
co-eluted with the residual sucrose added during extraction of the
SPMs (see Supplemental Table 1).
Changes in ganglioside levels during development and aging have
been reported previously, but most of these measures were obtained
from homogenates of rat [14], mouse [48], and human brains [16,49].
Therefore, it is not clear whether the changes in ganglioside content
reported in previous studies reﬂect age-related neuronal or glial
alterations. In the present study, we employed a fraction of neuronal
SPMs and observed signiﬁcant increases in the abundance of GM1 in
SPMs from the oldest rats. These ﬁndings are consistent with the age-
associated, high density clustering of GM1 at presynaptic terminals
reported previously [50]. Our observations showing no age-associated
changes in the fatty acid composition of either the C18:1 or C20:1
sphingosine component of all major brain gangliosides present in rat
synaptosomal fractions are also consistent with those reported previ-
ously [51]. The reason why GD1a content and GT1b content were ﬁrst
decreased at 23 months and restored at 34 months is unclear and
could be a compensatory mechanism for the neurons at 34 months to
overcome the effects of lower levels of the poly-sialogangliosides at
23 months.
Different types of gangliosides have been reported to produce
divergent effects on the activity of PMCA puriﬁed from either brainsynaptosomes or erythrocyte membranes and reconstituted into
liposomes [12,13]. In these studies, it was shown that the effects of
gangliosides on the activity of PMCA are related to the number of sialic
acid residues present in the gangliosides, with GD1b stimulating, GM1
reducing, and asialo-GM1 markedly inhibiting the PMCA activity. If
changes in the content of endogenous GM1 and GD1b in SPMs have
effects on the activity of membrane-attached PMCA that are similar to
those of exogenously added gangliosides, then we would predict that
the age-associated increases in GM1 and transient decreases in GD1b
in rat brain SPMs would lead to an overall age related reduction in neu-
ronal PMCA activity. To assess the validity of this idea, we chose to ma-
nipulate the total content of endogenous gangliosides as well as the
levels of the various ganglioside species.
We performed two manipulations to alter endogenous ganglioside
levels. One was aimed at suppressing the synthesis of both mono- and
poly-sialogangliosides by treating neurons with D-PDMP. The other
was designed to reduce the content of poly-sialogangliosides while
increasing the level of GM1 through treatment of primary neurons
with neuraminidase. Both manipulations decreased the activity of
PMCA without having a signiﬁcant effect on PMCA protein levels. Both
D-PDMP and L-PDMP, as well as the neuraminidase treatments, induced
slightmorphological changes in the neuronal cultures and caused similar
but small losses of total protein when treated cultures were compared
with untreated controls. But, whereas D-PDMP inhibited PMCA activity
signiﬁcantly, L-PDMP had no signiﬁcant effect on PMCA activity. This
selectivity suggests that it is the reduction in overall ganglioside content
in neurons treated with D-PDMP that caused decreases in enzyme
activity. Neuraminidase treatment of primary neurons led to an even
greater loss of PMCA activity than that seen with D-PDMP (39%
vs. 26%). As neuraminidase markedly increased GM1 while causing
signiﬁcant decreases in poly-sialogangliosides, it appears that poly-
sialogangliosides facilitate and GM1 reduces PMCA activity. Based on
these observations we suggest that the naturally occurring decreases
in the disialo- and trisialo-gangliosides at 23 months of age combined
with the increases in GM1 at 34 months of age might both contribute
to the loss of activity of neuronal PMCA during the aging process.
Conclusions about the role of gangliosides in PMCA regulation based
on the results of treatment of neurons with neuraminidase should be
tempered by the fact that such enzymatic treatment would cleave not
only sialic acid residues in gangliosides but also sialic acid residues in
glycoproteins. Thus, unlike the D-PDMP treatments that affect only the
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alter the environment of PMCA by changing the structure of both
gangliosides and glycoproteins. Moreover, with both D-PDMP and
neuraminidase treatments, gangliosides other than the ganglio series,
such as GD3 and GM3, were also decreased, which could contribute to
the PMCA activity loss. Finally, since all of the studies of neuraminidase
and D-PDMP treatments on PMCA activity were focused on the Ca2+-
activated ATP hydrolysis, additional studies are planned to alsomeasure
the effects of such manipulations on ATP-dependent Ca2+ transport in
neuronal preparations.
The mechanisms underlying the modulation of PMCA by ganglio-
sides remain undetermined. Gangliosidesmaymodulate PMCA function
either through direct interaction with the enzyme or through a broader
effect on the biophysical properties of the membrane lipid bilayer.
Previous studies of the effects of adding exogenous gangliosides to
liposome-reconstituted preparations of PMCA indicated that direct
interactions between gangliosides and the protein do occur [12]. How-
ever, our results from co-immunoprecipitation studies revealed that
endogenous gangliosides in SPMs may not interact directly with
PMCA or that the afﬁnity of such binding interactions is low and the
binding is readily reversible. This ﬁnding is consistentwith our assump-
tion that gangliosides, residing in the outer leaﬂet of the membrane
with their head-groups extending toward the extracellular medium,
may have transient, possibly low afﬁnity interactions with the PMCA
extracellular domain or theymay have an indirect effect on lipid bilayer
organization. It should be noted that 70% of the mass of the PMCA
protein and nearly all of the functional domains are on the cytoplasmic
side of the plasma membrane [52].
With regard to the effects of gangliosides on PMCA that may be
produced through changes in the overall membrane structure, it is
important to point out that an ordered lipid environment, such as that
in raft domains, increases the PMCA activity [30,34,53]. In the present
study, neither D-PDMP nor neuraminidase treatments altered themem-
brane cholesterol levels (data not shown). Thus the effects of the treat-
ments could not be ascribed to cholesterol depletion or enrichment of
the membranes. It has been suggested that the large hydrophilic head-
groups of gangliosides may help to form and stabilize membrane lipid
domains that exhibit a positive curvature [54]. Therefore, changes in
the carbohydrate units could affect the membrane curvature and inter-
molecular packing, thereby altering the three dimensional structure of
membrane proteins and leading to either their activation or inhibition
[54,55]. Also, the geometry of the gangliosides, which is determined
by the size of the head-groups, can modulate the ﬂuidity of the
membrane lipid core [54] and thus affect the activity of membrane-
associated enzymes. Amechanistic resolution of the various alternatives
must await more deﬁnitive biophysical measurements of ganglioside
effects on membrane structure. The results of such studies might shed
light on themechanisms underlying the effects of compositional changes
in gangliosides and their relationship to the loss of PMCA activity in
aging brain membranes.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2014.01.003.
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